IL2RA and colorectal cancer: In agreement, in the setting of colorectal cancer, CD8+FOXP3+CD25+ T-cells were significantly increased in peripheral blood and in colorectal cancer tissue, indicating that these cells may contribute to tumor immune escape and disease progression (69).